983.60p-1.80 (-0.18%)17 Apr 2025, 17:27
Jump to:
Smith & Nephew PLC Fundamentals
Company Name | Smith & Nephew PLC | Last Updated | 2025-04-17 |
---|---|---|---|
Industry | Medical Devices | Sector | Healthcare |
Shares in Issue | 875.028 m | Market Cap | £8.61 bn |
PE Ratio | 27.69 | Dividend per Share | $0.38 |
Dividend Yield | 2.94 | Dividend Cover | 1.23 |
EPS | $0.47 | EPS Growth (%) | 0.32 |
PEG | 0.86 | DPS Growth (%) | 0.0249 |
Debt Ratio | 0.3207 | Debt Equity Ratio | 0.6188 |
Asset Equity Ratio | 1.9666 | Cash Equity Ratio | 0.1176 |
Quick Ratio | 1.1927 | Current Ratio | 2.89 |
Price To Book Value | 2.1631 | ROCE | 0 |
Smith & Nephew PLC Dividends
Type | Ex-Date | Pay Date | Currency | Net Dividend | Year Total |
---|---|---|---|---|---|
Prelim | 2025-03-27 | 2025-05-28 | USD | 0.2310 | |
Interim | 2024-10-03 | 2024-11-08 | GBP | 0.1110 | |
Prelim | 2024-03-28 | 2024-05-22 | GBP | 0.1849 | |
Interim | 2023-10-05 | 2023-11-01 | GBP | 0.1189 | |
Prelim | 2023-03-30 | 2023-05-17 | GBP | 0.1838 | |
Interim | 2022-09-29 | 2022-10-26 | GBP | 0.1291 |
Smith & Nephew PLC Company Financials
Assets | 2024 | 2023 | 2022 |
---|---|---|---|
Tangible Assets | $1.42 bn | $1.47 bn | $1.46 bn |
Intangible Assets | $4.06 bn | $4.10 bn | $4.27 bn |
Investments | $16.00 m | $24.00 m | $58.00 m |
Total Fixed Assets | $5.93 bn | $5.96 bn | $6.11 bn |
Stocks | $2.39 bn | $2.40 bn | $2.21 bn |
Debtors | $1.21 bn | $1.18 bn | $1.14 bn |
Cash & Equivalents | $619.00 m | $302.00 m | $350.00 m |
Other Assets | $437.00 m | $361.00 m | $330.00 m |
Total Assets | $10.35 bn | $9.99 bn | $9.97 bn |
Liabilities | 2024 | 2023 | 2022 |
---|---|---|---|
Creditors within 1 year | $1.53 bn | $2.27 bn | $1.72 bn |
Creditors after 1 year | $3.56 bn | $2.50 bn | $2.99 bn |
Other Liabilities | 0 | 0 | 0 |
Total Liabilities | $5.09 bn | $4.77 bn | $4.71 bn |
Net assets | $5.26 bn | $5.22 bn | $5.26 bn |
Equity | 2024 | 2023 | 2022 |
---|---|---|---|
Called up share capital | $175.00 m | $175.00 m | $175.00 m |
Share Premium | $635.00 m | $635.00 m | $635.00 m |
Profit / Loss | $498.00 m | $290.00 m | $235.00 m |
Other Equity | $5.26 bn | $5.22 bn | $5.26 bn |
Preference & Minorities | 0 | 0 | 0 |
Total Capital Employed | $5.26 bn | $5.22 bn | $5.26 bn |
Ratios | 2024 | 2023 | 2022 |
---|---|---|---|
Debt Ratio | $0.38 | $0.31 | $0.34 |
Debt-to-Equity | $0.62 | $0.44 | $0.52 |
Assets / Equity | 1.9666 | 1.9666 | 1.9666 |
Cash / Equity | 0.1176 | 0.1176 | 0.1176 |
EPS | $0.66 | $0.51 | $0.46 |
Cash Flow | 2024 | 2023 | 2022 |
---|---|---|---|
Cash from operating activities | $987.00 m | $608.00 m | $468.00 m |
Cashflow before financing | $901.00 m | $408.00 m | -$458.00 m |
Increase in Cash | $332.00 m | -$40.00 m | -$930.00 m |
Income | 2024 | 2023 | 2022 |
---|---|---|---|
Turnover | $5.81 bn | $5.55 bn | $5.21 bn |
Cost of sales | $1.76 bn | $1.73 bn | $1.54 bn |
Gross Profit | $4.05 bn | $3.82 bn | $3.67 bn |
Operating Profit | $657.00 m | $425.00 m | $450.00 m |
Pre-Tax profit | $498.00 m | $290.00 m | $235.00 m |
Smith & Nephew PLC Company Background
Sector | Healthcare |
---|---|
Activities | Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder. |
Latest Interim Date | 1 Aug 2024 |
Latest Fiscal Year End Date | 25 Feb 2025 |
Smith & Nephew PLC Directors
Appointed | Name | Position |
---|---|---|
2018-04-12 | Mr. Joseph C. Papa | Independent Director |
2025-02-24 | Mr. Marc E. Owen | Non-Executive Director |
2019-04-11 | Dr. Michael A. Friedman M.D. | Non-Executive Director |
2018-05-07 | Mr. Olivier Bohuon | Director and Chief Executive Officer |
2014-07-31 | Dr. Pamela Josephine Kirby | Non-Executive Director |
2007-02-15 | Mr. Warren Decatur Knowlton | Non-Executive Director |
2012-12-31 | Mr. Adrian Nevil Hennah | Executive Director,Chief Financial Officer |
2017-04-06 | Mr. Brian Paul Larcombe | Independent Non-Executive Director |
2012-03-01 | Mr. David J. Illingworth | Executive Director,Chief Executive Officer |
2024-01-04 | Mr. Erik Engstrom | Non-Executive Director |
2014-04-10 | Mr. Richard Urbain de Schutter | Non-Executive Director |
2023-03-06 | Mr. Robin Anthony David Freestone | Non-Executive Director |
2004-12-16 | Dr. Rolf Wilhelm Heinrich Stomberg | Non-Executive Director |
2025-02-24 | Mr. Simon Jonathan Lowth | Non-Executive Director |
2011-08-09 | Sir Christopher John O'Donnell | Executive Director |
2019-04-11 | Mr. Ian E. Barlow | Non-Executive Director |
2023-09-15 | Mr. Roberto Quarta | Non-Executive Director,Chairman |
2014-04-10 | Sir John Buchanan | Non-Executive Director,Chairman |
2024-05-09 | Mr. Charles Richard Medlock | Non-Executive Director |
2025-02-24 | Mr. Rupert C Soames OBE | Non-Executive Director,Chairman |
2025-02-24 | Mr. Jeremy Kim Maiden | Non-Executive Director |
2025-02-24 | Ms. Angie Risley | Non-Executive Director,Senior Independent non-executive director |
2012-11-01 | Ms. Genevieve Berger | Non-Executive Director |
2025-03-27 | Mr. John Terence Rogers | Executive Director,Chief Financial Officer |
2021-04-14 | The Right Honourable Baroness Virginia Bottomley of Nettlestone, PC DL | Non-Executive Director |
2014-03-24 | Mr. Ajay G Piramal | Non-Executive Director |
2018-03-05 | Ms. Julie Brown | Executive Director,Chief Financial Officer |
2025-02-24 | Ms. Joanna Christine Hallas | Non-Executive Director |
2019-10-31 | Mr. Namal Nawana | Executive Director,Chief Executive Officer |
2024-03-29 | Ms. Anne-Francoise Nesmes | Executive Director,Chief Financial Officer |
2021-03-01 | Ms. Vinita Bali | Non-Executive Director |
2025-02-24 | Dr. Katarzyna Mazur-Hofsaess, PhD | Non-Executive Director |
2025-03-27 | Ms. Sybella Jane Stanley | Non-Executive Director |
2025-03-27 | Mr. Deepak S. Nath | Executive Director,Chief Executive Officer |
2020-04-09 | Mr. Graham Timothy Baker | Executive Director,Chief Financial Officer |
2025-02-24 | Mr. Robert J. White | Non-Executive Director |
2023-03-06 | Mr. Roland Daniel Diggelmann | Executive Director,Chief Executive Officer |
2025-02-24 | Dr. John Ma | Non-Executive Director |
Smith & Nephew PLC Contact Details
Company Name | Smith & Nephew PLC |
---|---|
Address | Hatters Lane, Building 5, Croxley Park, Watford, WD18 8YE |
Telephone | +44 7811270734 |
Website | https://www.smith-nephew.com |
Smith & Nephew PLC Advisors
Registrar | Computershare Investor Services PLC |
---|---|
Phone | +44 3707020003 |
Fax | +44 3707036101 |
Auditor | KPMG |
---|---|
Phone | +44 2073111000 |
Fax | +44 2073113311 |
Stockbroker | Bank of America Merrill Lynch |
---|---|
Phone | +44 2076281000 |
Fax | +44 2078672867 |
Financial PR Adviser | FTI Consulting Inc |
---|---|
Phone | +44 2037271000 |
Fax | +44 2037271007 |
Bank | National Westminster Bank PLC |
---|
Stockbroker | J.P. Morgan Cazenove Ltd |
---|---|
Phone | +44 2077424000 |
Bank | Lloyds Bank PLC |
---|
Remuneration Consultant | Willis Towers Watson |
---|---|
Phone | +44 2071702000 |
Fax | +44 2071702222 |
Solicitor | Ashurst LLP |
---|---|
Phone | +44 2076381111 |
Fax | +44 2076381112 |
Solicitor | Freshfields Bruckhaus Deringer |
---|---|
Phone | +44 2079364000 |
Fax | +44 2078327001 |
Solicitor | Pinsent Masons LLP |
---|---|
Phone | +44 2074187000 |
Fax | +44 2074187050 |
Solicitor | Squire Patton Boggs |
---|---|
Phone | +44 2076551000 |
Fax | +44 2076551001 |
Bank | Chase Manhattan Bank N.A. (The) |
---|
Auditor | EY |
---|---|
Phone | +44 2079512000 |
Fax | +44 2079511345 |
Auditor | Ernst & Young LLP |
---|
Most Read
Receive our
daily news email
Subscribe to the latest investing news by entering your email address below
You can opt out at any time.
For five days a week you will get
- The latest company news
- Insight into investment trends
- Round-up of director's buys and sells
- Articles from Shares magazine

Plus more useful investment content and occasional promotional offers.
Market Overview
UK 350 Risers and Fallers
Risers
Company | Price | % Chg |
---|---|---|
Dunelm Group PLC | 1,074.00 | 13.29 |
Asos PLC | 313.50 | 6.63 |
Rentokil Initial PLC | 350.00 | 5.01 |
Sainsbury (J) PLC | 256.80 | 3.55 |
Dr. Martens PLC | 52.80 | 3.53 |
Pershing Square Holdings LTD | 3,414.00 | 3.45 |
Fallers
Company | Price | % Chg |
---|---|---|
Dowlais Group PLC | 51.40 | -6.03 |
Fresnillo PLC | 1,021.00 | -5.55 |
Jupiter Fund Management PLC | 69.30 | -5.07 |
Goodwin PLC | 6,780.00 | -4.51 |
Spectris PLC | 1,987.00 | -4.38 |
Twentyfour Income Fund Limited | 108.60 | -3.89 |
Risers/fallers data from previous trading day. Today's data available from 8:15am.